[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100367440":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":18,"responsibleParty":38,"collaborators":40,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":55,"acronym":7,"eligibilityCriteria":56,"healthyVolunteers":53,"sex":57,"minAge":7,"maxAge":7,"enrollmentInfo":58,"targetDuration":61,"studyType":62,"phases":7,"briefSummary":63,"conditions":64,"keywords":71,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Newcastle-upon-Tyne Hospitals NHS Trust","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Chiara Marini Bettolo","PRINCIPAL_INVESTIGATOR",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Julie Bohill","CONTACT","0044 191 241 8640","julie.bohill@newcastle.ac.uk",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Newcastle University","RECRUITING","Newcastle upon Tyne","Tyne and Wear","NE1 3BZ","United Kingdom","UK",{"type":28,"coordinates":29},"Point",[30,31],-1.61396,54.97328,{"lat":31,"lon":30},[34,37],{"name":35,"role":15,"phone":16,"phoneExt":7,"email":36},"Jo Bullivant","joanne.bullivant@newcastle.ac.uk",{"name":10,"role":11,"phone":7,"phoneExt":7,"email":7},{"type":11,"investigatorFullName":10,"investigatorTitle":39,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Professor Neurologist and Clinical Lead, John Walton Muscular Dystrophy Research Centre. Clinical Lead of the Highly Specialised Service for Rare Neuromuscular Diseases, and Honorary Clinical Research Associate at Newcastle University",[41,44,46,49],{"name":42,"class":43},"Myotubular Trust","UNKNOWN",{"name":45,"class":43},"Muscular Dystrophy UK",{"name":47,"class":48},"Astellas Gene Therapies","INDUSTRY",{"name":50,"class":48},"Astellas Pharma Inc","100367440","myotubular-and-centronuclear-myopathy-patient-registry-100367440",false,"NCT04064307","Myotubular and Centronuclear Myopathy Patient Registry","Inclusion Criteria:\n\n* Patients with a myotubular myopathy or centronuclear myopathy diagnosis, which has been confirmed via genetic testing or muscle biopsy.\n* Any carrier females of x-linked myotubular myopathy, especially if they have manifested myotubular myopathy type symptoms.\n* Any patient who is deceased, but who had a confirmed diagnosis.\n\nExclusion Criteria:\n\n\\- None","ALL",{"count":59,"type":60},500,"ESTIMATED","1 Year","OBSERVATIONAL","The Myotubular and Centronuclear Myopathy Patient Registry (also referred to as the 'MTM and CNM Registry') is an international, patient-reported database specific to these conditions.\n\nMore details and online registration are available at www.mtmcnmregistry.org.",[65,66,67,68,69,70],"Myotubular Myopathy","Myotubular Myopathy 1","Myotubular (Centronuclear) Myopathy","Centronuclear Myopathy","Centronuclear Myopathy, X-Linked","X-linked Myotubular Myopathy",[72,73,74,75,76],"Registry","Patient Registry","Myotubular","Centronuclear","Myopathy","2025-04-07",{"date":79,"type":80},"2025-04-09","ACTUAL",{"date":82,"type":80},"2013-03-26",{"date":84,"type":60},"2025-05",{"name":5,"class":6},1]